During the recent session, Gilead Sciences, Inc (NASDAQ:GILD)’s traded shares were 0.78 million, with the beta value of the company hitting 0.30. At the last check today, the stock’s price was $110.43, reflecting an intraday gain of 1.83% or $1.99. The 52-week high for the GILD share is $119.96, that puts it down -8.63 from that peak though still a striking 43.79% gain since the share price plummeted to a 52-week low of $62.07. The company’s market capitalization is $137.36B, and the average trade volume was 9.77 million shares over the past three months.
Gilead Sciences, Inc (GILD) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.87. GILD has a Sell rating from 0 analyst(s) out of 17 analysts who have looked at this stock. 6 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 11 recommend a Buy rating for it.
Gilead Sciences, Inc (NASDAQ:GILD) trade information
Gilead Sciences, Inc (GILD) registered a 1.83% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 1.83% in intraday trading to $110.43, hitting a weekly high. The stock’s 5-day price performance is 2.51%, and it has moved by 5.96% in 30 days. Based on these gigs, the overall price performance for the year is 68.13%.
The consensus price target of analysts on Wall Street is $126, which implies an increase of 12.36% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $83 and $132 respectively. As a result, GILD is trading at a discount of -19.53% off the target high and 24.84% off the low.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -38.13%. While earnings are projected to return 73.01% in 2025, the next five years will return 25.74% per annum.
GILD Dividends
Gilead Sciences, Inc is due to release its next quarterly earnings in June. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance. Investors should also take the other fundamental and operational aspects into account before investing in the stock. The forward dividend ratio for Gilead Sciences, Inc is 3.10, with the dividend yield indicating at 2.81 percent, continuing the trend of increasing dividends in recent years.
Gilead Sciences, Inc (NASDAQ:GILD)’s Major holders
The next largest institutional holding, with 115.26 million shares, is of VANGUARD GROUP INC’s that is approximately 9.2431% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $7.91 billion.
Also, the Mutual Funds coming in first place with the largest holdings of Gilead Sciences, Inc (GILD) shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard 500 Index Fund. Data provided on Mar 31, 2025 indicates that VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund owns about 39.37 shares. This amounts to just over 3.16 percent of the company’s overall shares, with a $4.36 billion market value. The same data shows that the other fund manager holds slightly less at 34.63, or about 2.78% of the stock, which is worth about $3.83 billion.
